150 related articles for article (PubMed ID: 38609110)
21. MULTIPLE KERATINOCYTIC CANCERS AFTER ENALAPRIL/LOSARTAN INTAKE: POTENTIAL LINKS TO DRUG MEDIATED NITROSOGENESIS/CARCINOGENESIS: MELOLABIAL ADVANCED FLAP AND UNDERMINING SURGERY AS OPTIMAL THERAPEUTIC APPROACH.
Tchernev G
Georgian Med News; 2023 Nov; (344):196-199. PubMed ID: 38236123
[TBL] [Abstract][Full Text] [Related]
22. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract][Full Text] [Related]
23. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
Kalauz A; Tiringer KV; Horváth V; Kapui I
J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
[TBL] [Abstract][Full Text] [Related]
26. Biological interactions of N-nitroso compounds: a review.
Olajos EJ
Ecotoxicol Environ Saf; 1977 Sep; 1(2):175-96. PubMed ID: 361370
[TBL] [Abstract][Full Text] [Related]
27. Telmisartan (and/or nitrosamine) - induced occult melanoma: first reported case in world literature.
Tchernev G; Bitolska A; Patterson JW
Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1075-1080. PubMed ID: 34085580
[No Abstract] [Full Text] [Related]
28. Cutaneous chemical carcinogenesis.
Yuspa SH
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1031-44. PubMed ID: 3537025
[TBL] [Abstract][Full Text] [Related]
29. Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential.
Tricker AR; Preussmann R
Mutat Res; 1991; 259(3-4):277-89. PubMed ID: 2017213
[TBL] [Abstract][Full Text] [Related]
30. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.
Snodin DJ
Regul Toxicol Pharmacol; 2023 Jun; 141():105403. PubMed ID: 37116739
[TBL] [Abstract][Full Text] [Related]
31. A correlation between mutagenic and carcinogenic potencies in a diverse group of N-nitrosamines: determination of mutagenic activities of weakly mutagenic N-nitrosamines.
Lee SY; Guttenplan JB
Carcinogenesis; 1981; 2(12):1339-44. PubMed ID: 7034988
[TBL] [Abstract][Full Text] [Related]
32. From cultivation to cancer: formation of
Stanfill SB; Hecht SS; Joerger AC; González PJ; Maia LB; Rivas MG; Moura JJG; Gupta AK; Le Brun NE; Crack JC; Hainaut P; Sparacino-Watkins C; Tyx RE; Pillai SD; Zaatari GS; Henley SJ; Blount BC; Watson CH; Kaina B; Mehrotra R
Crit Rev Toxicol; 2023 Nov; 53(10):658-701. PubMed ID: 38050998
[TBL] [Abstract][Full Text] [Related]
33. METATYPICAL BCCS OF THE NOSE TREATED SUCCESSFULLY VIA BILOBED TRANSPOSITION FLAP: NITROSAMINES IN ACES (ENALAPRIL), ARBS (LOSARTAN) AS POSSIBLE SKIN CANCER KEY TRIGGERING FACTOR.
Tchernev G; Kordeva S; Lozev I
Georgian Med News; 2023 Feb; (335):22-25. PubMed ID: 37042583
[TBL] [Abstract][Full Text] [Related]
34. Metabolic Activation and DNA Interactions of Carcinogenic
Li Y; Hecht SS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562949
[TBL] [Abstract][Full Text] [Related]
35. Carcinogenicity and mutagenicity of N-nitroso compounds.
Lijinsky W
Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
[TBL] [Abstract][Full Text] [Related]
36. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
[TBL] [Abstract][Full Text] [Related]
37. Predicting DNA-Reactivity of N-Nitrosamines: A Quantum Chemical Approach.
Wenzel J; Schmidt F; Blumrich M; Amberg A; Czich A
Chem Res Toxicol; 2022 Nov; 35(11):2068-2084. PubMed ID: 36302168
[No Abstract] [Full Text] [Related]
38. Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity.
Glowienke S; Onken U; Elhajouji A; Muthusamy S; Sangana R; Martus HJ; Bedman T; Hartmann A
Regul Toxicol Pharmacol; 2022 Oct; 134():105245. PubMed ID: 35988810
[TBL] [Abstract][Full Text] [Related]
39. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
[TBL] [Abstract][Full Text] [Related]
40. The biochemistry of nitrates, nitrites, nitrosamines and other potential carcinogens in human saliva.
Tenovuo J
J Oral Pathol; 1986 Jul; 15(6):303-7. PubMed ID: 3093650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
